Literature DB >> 10577907

Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.

L Ying1, Y Katz, M Schlesinger, R Carmi, H Shalev, N Haider, G Beck, V C Sheffield, D Landau.   

Abstract

Atypical hemolytic uremic syndrome (HUS) presents with the clinical features of hypertension, microangiopathic hemolytic anemia, and acute renal failure. Both dominant and recessive modes of inheritance have been reported. This study describes the genetic and functional analysis of a large Bedouin kindred with autosomal recessive HUS. The kindred consists of several related nuclear families in which all parent unions of affected children are consanguineous. A previous report demonstrated that a dominant form of HUS maps to chromosome 1q and that complement factor H (CFH), a regulatory component of the complement system, lies within the region and is involved in the dominant disorder. Early-onset and persistent hypocomplementemia in this Bedouin kindred prompted us to evaluate the CFH gene. Linkage analysis was performed, demonstrating linkage between the disorder and the markers near the CFH gene. Mutation analysis of the CFH coding region revealed a single missense mutation. Functional analyses demonstrate that the mutant CFH is properly expressed and synthesized but that it is not transported normally from the cell. This is the first study reporting that a recessive, atypical, early-onset, and relapsing HUS is associated with the CFH protein and that a CFH mutation affects intracellular trafficking and secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577907      PMCID: PMC1288364          DOI: 10.1086/302673

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Simplified northern blot hybridization using 5% sodium dodecyl sulfate.

Authors:  G D Virca; W Northemann; B R Shiels; G Widera; S Broome
Journal:  Biotechniques       Date:  1990-04       Impact factor: 1.993

2.  Fast and sensitive silver staining of DNA in polyacrylamide gels.

Authors:  B J Bassam; G Caetano-Anollés; P M Gresshoff
Journal:  Anal Biochem       Date:  1991-07       Impact factor: 3.365

3.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

4.  Recurrent haemolytic-uraemic syndrome with hypocomplementaemia: a case report.

Authors:  R Bogdanović; A Cvorić; V Nikolić; M Sindjić
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

Review 5.  Genetics and deficiencies of the soluble regulatory proteins of the complement system.

Authors:  R B Sim; K Kölble; M A McAleer; O Dominguez; V M Dee
Journal:  Int Rev Immunol       Date:  1993       Impact factor: 5.311

6.  Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.

Authors:  S Meri; M K Pangburn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  A collection of ordered tetranucleotide-repeat markers from the human genome. The Utah Marker Development Group.

Authors: 
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

8.  Familial hemolytic-uremic syndrome and homozygous factor H deficiency.

Authors:  V Pichette; S Quérin; W Schürch; G Brun; G Lehner-Netsch; J M Delâge
Journal:  Am J Kidney Dis       Date:  1994-12       Impact factor: 8.860

9.  Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H.

Authors:  M Ohali; H Shalev; M Schlesinger; Y Katz; L Kachko; R Carmi; S Sofer; D Landau
Journal:  Pediatr Nephrol       Date:  1998-10       Impact factor: 3.714

10.  Inherited factor H deficiency and collagen type III glomerulopathy.

Authors:  B A Vogt; R J Wyatt; B A Burke; S C Simonton; C E Kashtan
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

View more
  24 in total

1.  Concomitant anuric post-streptococcal glomerulonephritis and autoimmune hemolytic anemia.

Authors:  Francois Cachat; Kim Dunsmore; Alda Tufro
Journal:  Eur J Pediatr       Date:  2003-05-10       Impact factor: 3.183

2.  Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Authors:  Meredith A Bostrom; W H Linda Kao; Man Li; Hanna E Abboud; Sharon G Adler; Sudha K Iyengar; Paul L Kimmel; Robert L Hanson; Susanne B Nicholas; Rebekah S Rasooly; John R Sedor; Josef Coresh; Orly F Kohn; David J Leehey; Denyse Thornley-Brown; Erwin P Bottinger; Michael S Lipkowitz; Lucy A Meoni; Michael J Klag; Lingyi Lu; Pamela J Hicks; Carl D Langefeld; Rulan S Parekh; Donald W Bowden; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2011-11-25       Impact factor: 8.860

Review 3.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

4.  Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiency.

Authors:  Katell Michaux; Justine Bacchetta; Etienne Javouhey; Pierre Cochat; Véronique Frémaux-Bacchi; Anne-Laure Sellier-Leclerc
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

Review 5.  Genetic kidney diseases in the pediatric population of southern Israel.

Authors:  Gal Finer; Hanna Shalev; Daniel Landau
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

6.  Determination of complement factor H functional polymorphisms (V62I, Y402H, and E936D) using sequence-specific primer PCR and restriction fragment length polymorphisms.

Authors:  Adrienn Bíró; Zoltán Prohászka; George Füst; Bernadett Blaskó
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  Complement factor H gene associations with end-stage kidney disease in African Americans.

Authors:  Jason A Bonomo; Nicholette D Palmer; Pamela J Hicks; Janice P Lea; Mark D Okusa; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2014-02-28       Impact factor: 5.992

8.  Idiopathic Atypical Hemolytic Uremic Syndrome (aHUS) with Trilineage Myelodysplasia.

Authors:  Sudha Sethy; S R Mahapatra; R K Jena; P Bhunya; S Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2011-07-12       Impact factor: 0.900

9.  Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

Authors:  Anna Richards; Elizabeth J Kemp; M Kathryn Liszewski; Judith A Goodship; Anne K Lampe; Ronny Decorte; M Hamza Müslümanoğlu; Salih Kavukcu; Guido Filler; Yves Pirson; Leana S Wen; John P Atkinson; Timothy H J Goodship
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

10.  Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.

Authors:  H P H Neumann; M Salzmann; B Bohnert-Iwan; T Mannuelian; C Skerka; D Lenk; B U Bender; M Cybulla; P Riegler; A Königsrainer; U Neyer; A Bock; U Widmer; D A Male; G Franke; P F Zipfel
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.